The approval of brensocatib for use in patients with bronchiectasis could offer the first treatment directly addressing the roots of the condition. What is bronchiectasis and how can the condition be ...
How finally accepting her diagnosis and being proactive with her health helped one woman manage her lung condition.
Insmed's freshly approved lung condition drug soared past sales expectations for 2025, netting $144.6 million in its first ...
The lung disease bronchiectasis plays out as a vicious cycle. Infection leads to inflammation followed by the impaired ability to clear the excess mucus coughed up from the lungs. These problems lead ...
British scientists have found the first-ever treatment for bronchiectasis, the disease Pope Francis was hospitalized with in the weeks prior to his death, The Telegraph reported. Francis suffered from ...
— BRINSUPRI Was Reviewed Under EMA's Accelerated Assessment Pathway as It Is Considered of Major Interest for Public Health — NCFB is a chronic and progressive disease that can lead to permanent lung ...
Please provide your email address to receive an email when new articles are posted on . For adults with bronchiectasis, $82,545 was the highest annual health care cost observed in a systematic review.
Please provide your email address to receive an email when new articles are posted on . Brensocatib given as 25 mg performed better than placebo when assessing rate of pulmonary exacerbations and lung ...
Researchers analyzed a US national database to compare outcomes of hospitalizations for bronchiectasis exacerbations with those for COPD and asthma exacerbations among adults hospitalized between 2017 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback